The drug industry's voice for manufacturing excellence
Production
Development
Information Technology
Compliance
Quality & Risk
Sections
Production
Development
Information Technology
Compliance
Quality & Risk
Facilities
Sectors
Special
Webinars
Podcasts
E-Handbooks
Industry News
Magazine Archives
Contact
Newsletter Subscription
Contact Us
Advertise
Follow us on
https://www.facebook.com/pages/Pharmaceutical-Manufacturing/140261116014887
http://www.linkedin.com/groups?gid=1813799
http://twitter.com/PharmaMfg
Compliance
Compliance
Thermo Fisher CEO says Most Favored Nation and tariff policies are better than feared
Marc Casper contends Thermo Fisher’s pharma and biotech customers will be able to navigate the Trump administration’s MFN drug pricing framework and tariffs.
Oct. 22, 2025
Sponsored
Corporate compliance involves more than just cGMP and quality
Oct. 17, 2025
Compliance
Trump’s pharma tariff threat brings AstraZeneca to heel with drug pricing agreement
Oct. 10, 2025
Regulatory Guidance
FDA launches pilot to speed up review for US generic drug manufacturing, testing
Oct. 6, 2025
Compliance
Trump’s Oct. 1 pharma tariff is on hold amid pricing talks with drugmakers
Oct. 2, 2025
Compliance
Pfizer agrees to lower US drug prices, locks in three-year tariff grace period
Oct. 1, 2025
Regulatory Guidance
FDA program to lower US onshoring barriers gets industry support
Oct. 1, 2025
Compliance
Trump says some drugmakers face a 100% pharma tariff on October 1
Sept. 26, 2025
cGMPs
US onshoring is too slow, complex to drive near-term tailwind in bioprocessing
Sept. 23, 2025
Looking for Something?
Load More Content
Back To Top
